Antibody to the human OX40 receptor

Details Antibody to the human OX40 receptor Antibody to the human OX40 receptor

2003-06-13

2009-06-23

Spector, Lorraine (Department: 1647)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

C424S139100, C424S178100, C514S012200, C435S331000

Reexamination Certificate

active

07550140

ABSTRACT:
The present invention provides binding molecules, such as human binding molecules, that bind to and stimulate the human OX40-receptor. The invention also provides nucleic acids encoding such binding molecules. Methods for producing such binding molecules are also provided by the present invention. The binding molecules and nucleic acids are useful in the stimulation of human T-cells and can be used to enhance antigen-specific immune responses.

REFERENCES:
patent: 5696100 (1997-12-01), Holme et al.
patent: 5821332 (1998-10-01), Godfrey et al.
patent: 6265150 (2001-07-01), Terstappen et al.
patent: 6277962 (2001-08-01), Godfrey et al.
patent: 6312700 (2001-11-01), Weinberg
patent: 2001/0044522 (2001-11-01), Godfrey et al.
patent: WO 98/15833 (1998-04-01), None
patent: WO 99/42585 (1999-08-01), None
patent: WO 03/106498 (2003-12-01), None
patent: WO 95/12673 (2003-12-01), None
Vajdos et al., Comprehensive Functional Maps of the Antigen-binding Site of an Anti-ErbB2 Antibody Obtained with Shotgun Scanning Mutagenesis. J. Mol. Biol., 320: 415-428, 2002.
Beiboer et al., Guided selection of a pan-Carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent. J.Mol. Biol. 296, 833-849, 2000.
MacCallum et al., Antibody-antigen Interactions: Contact Analysis an dBinding Site Topgraphy. J. Mol. Biol. 262: 732-745, 1996.
Klimka et al., Human anti-CD30 Reccombinant antibodies guided phage antibody selection using cell panning. British J. Cancer., 83, 252-260, 2000.
PCT International Search Report, PCT/EP2003/106498, dated Jan. 7, 2004.
Vaughan et al., “Human antibodies by design,” Nature Biotechnology, Jun. 1998, pp. 535-539, vol. 16.
Weinberg et al., “Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity,” Journal of Immunology, Feb. 15, 2000, pp. 2160-2169, vol. 164, No. 4.
Weinberg, A., “OX40: targeted immunotherapy - implications for tempering autoimmunity and enhancing vaccines,” Trends in Immunology, Feb. 2002, pp. 102-109, vol. 23, No. 2.
PCT International Search Report, PCT/EP03/06341, dated Jan. 1, 2004.
PCT International Preliminary Examination Report, PCT/EP03/06341, dated Jul. 21, 2004.

Affiliated with

Also associated with

Rating

Antibody to the human OX40 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibody to the human OX40 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody to the human OX40 receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4142871